Morepen Labs: 150% return expected in this counter

Morepen Laboratories,smallcap company, is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.
Planning of capacity expansion and is taking aggressive steps to penetrate into the API business.Got approval to manufacture sputnik V in India.

Points to be noted:
Trading at P/E of 40 which is equivalent to avg P/E of the industry.
Net profit growth rate and sales growth higher than industry average growth demand higher P/E for the stock.
Company has reduced debt drastically.
Company has delivered good profit growth of 41.36% CAGR over last 5 years
Any 3rd wave as such or any fear of virus would further improve the sales of morepen.
Company is improving its business on QoQ basis continuously.

The numbers recorded by Morepen Labs is highest of all time on all the fronts as far as financials are considered which will least expect the price to reach its all time high i.e 175, which is a 150% return from hereon. However, the technical targets and stop loss are mentioned in the chart.

#TradeTheTrend#SmallCap#MultiBagger
Chart PatternsFundamental AnalysisTechnical Indicators

Penafian